Cargando…

Myocardial Late Iodine Enhancement Using Photon-Counting Computed Tomography in Patients With Hypertrophic Cardiomyopathy

Detalles Bibliográficos
Autores principales:	Nishihara, Takahiro, Miyoshi, Toru, Akagi, Noriaki, Nakashima, Mitsutaka, Nakamura, Kazufumi, Ito, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2023
Materias:	Images in Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247347/ https://www.ncbi.nlm.nih.gov/pubmed/37305798 http://dx.doi.org/10.1253/circrep.CR-23-0034

Ejemplares similares

Association between Cardiovascular Disease and Liver Disease, from a Clinically Pragmatic Perspective as a Cardiologist
por: Nakashima, Mitsutaka, et al.
Publicado: (2023)

Free-Breathing Motion-Corrected Single-Shot Phase-Sensitive Inversion Recovery Late-Gadolinium-Enhancement Imaging: A Prospective Study of Image Quality in Patients with Hypertrophic Cardiomyopathy
por: Cha, Min Jae, et al.
Publicado: (2021)

Pressure Tracings in Hypertrophic Cardiomyopathy With Dynamic Midventricular Obstruction
por: Jung, Hee-Chan, et al.
Publicado: (2012)

Trileaflet Mitral Valve: An Unusual Contributor of Mitral Regurgitation in Hypertrophic Cardiomyopathy
por: Nalawade, Digvijay D., et al.
Publicado: (2023)

Effect of Papillary Muscles and Trabeculae on Left Ventricular Measurement Using Cardiovascular Magnetic Resonance Imaging in Patients with Hypertrophic Cardiomyopathy
por: Park, Eun-Ah, et al.
Publicado: (2015)

Pemafibrate Prevents Rupture of Angiotensin II-Induced Abdominal Aortic Aneurysms
por: Amioka, Naofumi, et al.
Publicado: (2022)

Exuberant late gadolinium enhancement in hypertrophic cardiomyopathy as a precursor to ‘burn out’
por: Gweun, John, et al.
Publicado: (2022)

Novel Resectable Myocardial Model Using Hybrid Three-Dimensional Printing and Silicone Molding for Mock Myectomy for Apical Hypertrophic Cardiomyopathy
por: Kim, Wooil, et al.
Publicado: (2021)

Rapid Fatal Progression and Autopsy Findings of Effusive-Constrictive Pericarditis With Hypertrophic Cardiomyopathy
por: Hiruma, Takashi, et al.
Publicado: (2023)

Mid-Ventricular Hypertrophic Obstructive Cardiomyopathy Complicated by an Apical Aneurysm, Presenting as Ventricular Tachycardia
por: Petrou, Emmanouil, et al.
Publicado: (2014)

A Rare Cause of Syncope: Apical Biventricular Hypertrophic Cardiomyopathy Complicated by Atrial Flutter
por: Cinar, Tufan, et al.
Publicado: (2020)

Unmasked Obstructive Hypertrophic Cardiomyopathy after Mitral Valve Repair for Severe Mitral Regurgitation
por: Kim, Darae, et al.
Publicado: (2020)

Impact of malnutrition on prognosis in patients with pulmonary arterial hypertension
por: Nakashima, Mitsutaka, et al.
Publicado: (2023)

Late Iodine Enhancement and Extracellular Volume Fraction in Cardiac Amyloidosis by Computed Tomography
por: Suzuki, Masataka, et al.
Publicado: (2022)

Association between higher pericoronary adipose tissue attenuation measured by coronary computed tomography angiography and nonalcoholic fatty liver disease: A matched case-control study
por: Ichikawa, Keishi, et al.
Publicado: (2021)

Association of Oxidized Low-Density Lipoprotein in Nonalcoholic Fatty Liver Disease with High-Risk Plaque on Coronary Computed Tomography Angiography: A Matched Case–Control Study
por: Nishihara, Takahiro, et al.
Publicado: (2022)

In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging
por: Saito, Yukihiro, et al.
Publicado: (2023)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease
por: Liu, Shengliang, et al.
Publicado: (2022)

Fabry Disease that Phenocopies Hypertrophic Cardiomyopathy: a thorough Genetic ‘Detective’ Identifies the ‘Rogue’ Hidden in the GLA Gene
por: Kwon, Soonil, et al.
Publicado: (2019)

Sigmoid Septum and Aberrant Calcified Papillary Muscle in the Setting of Advanced Hypertrophic Cardiomyopathy: An Unusual Life-threatening Coalescence
por: Hallo, Carlos, et al.
Publicado: (2019)

Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
por: Cheng, Zeyi, et al.
Publicado: (2021)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Fibro-fatty Degeneration in Hypertrophic Cardiomyopathy
por: Chaikriangkrai, Kongkiat, et al.
Publicado: (2018)

Cardiac Catheterization in a Patient with Obstructive Hypertrophic Cardiomyopathy and Syncope
por: Nunes, Rafael Amorim Belo, et al.
Publicado: (2017)

The Association of Triglyceride to High-Density Lipoprotein Cholesterol Ratio with High-Risk Coronary Plaque Characteristics Determined by CT Angiography and Its Risk of Coronary Heart Disease
por: Koide, Yuji, et al.
Publicado: (2022)

Association of perivascular fat attenuation on computed tomography and heart failure with preserved ejection fraction
por: Nishihara, Takahiro, et al.
Publicado: (2023)

Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy
por: Ye, Yang, et al.
Publicado: (2021)

Comprehensive Proteomics Profiling Identifies Patients With Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in the Hypertrophic Cardiomyopathy Population
por: Lander, Bradley S., et al.
Publicado: (2022)

Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy
por: He, Chao-Jie, et al.
Publicado: (2022)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy
por: Ismail, Haneen, et al.
Publicado: (2022)

Dual apical hypertrophic cardiomyopathy and endomyocardial fibrosis pathology
por: Martini, Chiara, et al.
Publicado: (2023)

The effect of luseogliflozin and alpha-glucosidase inhibitor on heart failure with preserved ejection fraction in diabetic patients: rationale and design of the MUSCAT-HF randomised controlled trial
por: Ejiri, Kentaro, et al.
Publicado: (2019)

The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study
por: Kim, Eun Kyoung, et al.
Publicado: (2021)

Non-pharmaceutical Interventions for Hypertrophic Cardiomyopathy: A Mini Review
por: He, Miaomiao, et al.
Publicado: (2021)

COVID-19 INFECTION IN A PATIENT WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: AFRAZ PASHA, MOHAMMED, et al.
Publicado: (2021)

Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
por: Butzner, Michael, et al.
Publicado: (2022)

Further Considerations in Childhood-Onset Hypertrophic Cardiomyopathy Genetic Testing
por: Monasky, Michelle M., et al.
Publicado: (2021)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_810m97rfok67o2qi467ivjend4